Hong Kong vs Lebanon: HIV-positive TB patients on ART (antiretroviral therapy)
Hong Kong
100.0%
in 2024
Lebanon
100.0%
in 2024
Hong Kong rank
1st
Lebanon rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Hong Kong
- Lebanon
How they compare
Hong Kong currently reports 100.0% against 100.0% in Lebanon, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2007 it was Lebanon ahead.
Hong Kong ranks 1st and Lebanon ranks 1st of 144 countries.
Across the 3 decades both report, Hong Kong averaged higher in 1 and Lebanon in 2.
Head to head by decade
| Decade | Hong Kong | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.7% | 100.0% | 58.3% | Lebanon |
| 2010s | 31.1% | 80.8% | 49.8% | Lebanon |
| 2020s | 93.5% | 91.8% | 1.8% | Hong Kong |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Hong Kong or Lebanon?
- Hong Kong, at 100.0% against 100.0% in Lebanon as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Hong Kong and Lebanon?
- 0.0%, with Hong Kong ahead.
- How many years of comparable data are there for Hong Kong and Lebanon?
- 13 years are reported by both, from 2007 to 2024.
- How do Hong Kong and Lebanon rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Hong Kong ranks 1st and Lebanon ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.